BARI-INSIGHT: A Double-blind, Placebo-controlled, Within-subject, Cross-over Mechanistic Study Investigating the Role of Ghrelin in Regulating Appetite and Energy Intake in Patients Following Bariatric Surgery
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2019
Price : $35 *
At a glance
- Drugs GLWL 01 (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms BARI-INSIGHT
- 25 Apr 2019 Status changed from not yet recruiting to recruiting.
- 12 Nov 2018 Planned End Date changed from 15 Mar 2020 to 30 Mar 2020.
- 12 Nov 2018 Planned primary completion date changed from 30 Sep 2019 to 30 Nov 2019.